Perez, Conchita L.
HRN: 20-58-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/02/2022
09/08/2022
IV
500mg
TID
Tetanus Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes